지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2023.1
- 수록면
- 3 - 17 (15page)
- DOI
- 10.4078/jrd.22.0046
이용수
초록· 키워드
오류제보하기
Osteoporosis is a systemic skeletal disorder that causes vulnerability of bones to fracture owing to reduction in bone density and deterioration of the bone tissue microstructure. The prevalence of osteoporosis is higher in patients with autoimmune inflammatory rheumatic diseases, including rheumatoid arthritis (RA), than in those of the general population. In this autoimmune inflammatory rheumatic disease, in addition to known risk factors for osteoporosis, various factors such as chronic inflammation, autoantibodies, metabolic disorders, drugs, and decreased physical activity contribute to additional risk. In RA, disease-related inflammation plays an important role in local or systemic bone loss, and active treatment for inflammation can help prevent osteoporosis. In addition to conventional synthetic disease-modifying anti-rheumatic drugs that have been traditionally used for treatment of RA, biologic DMARDs and targeted synthetic DMARDs have been widely used. These agents can be employed more selectively and precisely based on disease pathogenesis. It has been reported that these drugs can inhibit bone loss by not only reducing inflammation in RA, but also by inhibiting bone resorption and promoting bone formation. In this review, the pathogenesis and research results of the increase in osteoporosis in RA are reviewed, and the effects of biological agents on osteoporosis are discussed.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
남성 골다공증의 위험 요인에 대한 최신 지견과 공중보건학적 중재 전략
보건교육건강증진학회지
2023 .06
-
Pro-inflammatory Cytokines Modulating Osteoclast Differentiation and Function
대한류마티스학회지
2016 .01
-
Clinical characteristics of osteoporosis in patients with rheumatoid arthritis: Disease activity matters
Osteoporosis and Sarcopenia
2020 .01
-
Compliance and discontinuation of denosumab treatment in postmenopausal Japanese women with primary osteoporosis or rheumatoid arthritis and osteoporosis
Osteoporosis and Sarcopenia
2017 .01
-
Up-to-Date Knowledge on Osteoporosis Treatment Selection in Postmenopausal Women
대한폐경학회지
2022 .12
-
Medical treatment of severe osteoporosis including new concept of advanced severe osteoporosis
Osteoporosis and Sarcopenia
2016 .01
-
Comparison in Adherence to Osteoporosis Guidelines according to Bone Health Status in Korean Adult
대한골대사학회지
2016 .01
-
More research and education of osteoporosis should be focused on the oldest old and men
Osteoporosis and Sarcopenia
2019 .01
-
The Impact of Educational Interventions on Osteoporosis Knowledge among Korean Osteoporosis Patients
대한골대사학회지
2018 .01
-
Osteoporosis Associated with Chronic Obstructive Pulmonary Disease
대한골대사학회지
2016 .01
-
Environmental Air Pollution and the Risk of Osteoporosis and Bone Fractures
예방의학회지
2018 .01
-
Environmental Air Pollution and the Risk of Osteoporosis and Bone Fractures
예방의학회지
2018 .01
-
New Biological Markers of Bone Metabolism in Osteoporosis Treatment
Endocrinology and Metabolism
2016 .01
-
Biological characteristics of osteoporosis drugs: the effect of osteoblast–osteoclast coupling
International Journal of Oral Biology
2019 .01
-
류마티스관절염의 약물치료
대한의사협회지
2017 .01
-
Evaluation of the Predictive Index for Osteoporosis as a Clinical Tool to Identify the Risk of Osteoporosis in Korean Men by Using the Korea National Health and Nutrition Examination Survey Data
Korean Journal of Family Medicine
2016 .01
-
골다공증 한약제제 임상시험 참여자의골다공증 한의치료에 대한 인식 : 질적 연구
대한한방내과학회지
2017 .01
-
Sharing Pathological Mechanisms of Insomnia and Osteoporosis, and a New Perspective on Safe Drug Choice
대한폐경학회지
2018 .01
-
The Effects of a Group Educational Intervention on the Prevention of Osteoporosis in Breast Cancer Patients
지역사회간호학회지
2015 .12
-
The Impact of COVID-19 on the Optimal Management of Osteoporosis
대한골대사학회지
2021 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0